Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros










Intervalo de ano de publicação
2.
Cell Death Differ ; 31(2): 170-187, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38062245

RESUMO

The Sonic Hedgehog (SHH) pathway is crucial regulator of embryonic development and stemness. Its alteration leads to medulloblastoma (MB), the most common malignant pediatric brain tumor. The SHH-MB subgroup is the best genetically characterized, however the molecular mechanisms responsible for its pathogenesis are not fully understood and therapeutic benefits are still limited. Here, we show that the pro-oncogenic stemness regulator Spalt-like transcriptional factor 4 (SALL4) is re-expressed in mouse SHH-MB models, and its high levels correlate with worse overall survival in SHH-MB patients. Proteomic analysis revealed that SALL4 interacts with REN/KCTD11 (here REN), a substrate receptor subunit of the Cullin3-RING ubiquitin ligase complex (CRL3REN) and a tumor suppressor lost in ~30% of human SHH-MBs. We demonstrate that CRL3REN induces polyubiquitylation and degradation of wild type SALL4, but not of a SALL4 mutant lacking zinc finger cluster 1 domain (ΔZFC1). Interestingly, SALL4 binds GLI1 and cooperates with HDAC1 to potentiate GLI1 deacetylation and transcriptional activity. Notably, inhibition of SALL4 suppresses SHH-MB growth both in murine and patient-derived xenograft models. Our findings identify SALL4 as a CRL3REN substrate and a promising therapeutic target in SHH-dependent cancers.


Assuntos
Neoplasias Encefálicas , Neoplasias Cerebelares , Meduloblastoma , Animais , Humanos , Camundongos , Proteínas de Ciclo Celular , Neoplasias Cerebelares/genética , Neoplasias Cerebelares/patologia , Proteínas Hedgehog/metabolismo , Meduloblastoma/genética , Proteômica , Fatores de Transcrição/genética , Transferases , Proteína GLI1 em Dedos de Zinco/genética
3.
J Neurooncol ; 163(1): 143-158, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-37183219

RESUMO

PURPOSE: We and others have demonstrated that MYC-amplified medulloblastoma (MB) cells are susceptible to class I histone deacetylase inhibitor (HDACi) treatment. However, single drug treatment with HDACi has shown limited clinical efficacy. We hypothesized that addition of a second compound acting synergistically with HDACi may enhance efficacy. METHODS: We used a gene expression dataset to identify PLK1 as a second target in MB cells and validated the relevance of PLK1 in MB. We measured cell metabolic activity, viability, and cycle progression in MB cells after treatment with PLK1-specific inhibitors (PLK1i). Chou-Talalay synergy calculations were used to determine the nature of class I HDACi entinostat and PLK1i interaction which was validated. Finally, the clinical potential of the combination was assessed in the in vivo experiment. RESULTS: MYC-amplified tumor cells are highly sensitive towards treatment with ATP-competitive PLK1i as a monotherapy. Entinostat and PLK1i in combination act synergistically in MYC-driven MB cells, exerting cytotoxic effects at clinically relevant concentrations. The downstream effect is exerted via MYC-related pathways, pointing out the potential of MYC amplification as a clinically feasible predictive biomarker for patient selection. While entinostat significantly extended survival of mice implanted with orthotopic MYC-amplified MB PDX, there was no evidence of the improvement of survival when treating the animals with the combination. CONCLUSION: The combination of entinostat and PLK1i showed synergistic interaction in vitro, but not in vivo. Therefore, further screening of blood-brain barrier penetrating PLK1i is warranted to determine the true potential of the combination as no on-target activity was observed after PLK1i volasertib treatment in vivo.


Assuntos
Antineoplásicos , Neoplasias Cerebelares , Meduloblastoma , Camundongos , Animais , Inibidores de Histona Desacetilases/farmacologia , Inibidores de Histona Desacetilases/uso terapêutico , Meduloblastoma/tratamento farmacológico , Meduloblastoma/metabolismo , Antineoplásicos/uso terapêutico , Neoplasias Cerebelares/tratamento farmacológico , Linhagem Celular Tumoral
4.
Nat Commun ; 13(1): 4061, 2022 07 13.
Artigo em Inglês | MEDLINE | ID: mdl-35831316

RESUMO

Most lncRNAs display species-specific expression patterns suggesting that animal models of cancer may only incompletely recapitulate the regulatory crosstalk between lncRNAs and oncogenic pathways in humans. Among these pathways, Sonic Hedgehog (SHH) signaling is aberrantly activated in several human cancer entities. We unravel that aberrant expression of the primate-specific lncRNA HedgeHog Interacting Protein-AntiSense 1 (HHIP-AS1) is a hallmark of SHH-driven tumors including medulloblastoma and atypical teratoid/rhabdoid tumors. HHIP-AS1 is actively transcribed from a bidirectional promoter shared with SHH regulator HHIP. Knockdown of HHIP-AS1 induces mitotic spindle deregulation impairing tumorigenicity in vitro and in vivo. Mechanistically, HHIP-AS1 binds directly to the mRNA of cytoplasmic dynein 1 intermediate chain 2 (DYNC1I2) and attenuates its degradation by hsa-miR-425-5p. We uncover that neither HHIP-AS1 nor the corresponding regulatory element in DYNC1I2 are evolutionary conserved in mice. Taken together, we discover an lncRNA-mediated mechanism that enables the pro-mitotic effects of SHH pathway activation in human tumors.


Assuntos
Neoplasias Cerebelares , Meduloblastoma , MicroRNAs , RNA Longo não Codificante , Animais , Proteínas de Transporte/metabolismo , Linhagem Celular Tumoral , Proliferação de Células , Neoplasias Cerebelares/genética , Dineínas/metabolismo , Regulação Neoplásica da Expressão Gênica , Proteínas Hedgehog/genética , Proteínas Hedgehog/metabolismo , Humanos , Meduloblastoma/genética , Glicoproteínas de Membrana/metabolismo , Camundongos , MicroRNAs/genética , RNA Longo não Codificante/genética
7.
Nat Commun ; 10(1): 3304, 2019 07 24.
Artigo em Inglês | MEDLINE | ID: mdl-31341163

RESUMO

The Hedgehog (Hh) pathway is essential for embryonic development and tissue homeostasis. Aberrant Hh signaling may occur in a wide range of human cancers, such as medulloblastoma, the most common brain malignancy in childhood. Here, we identify endoplasmic reticulum aminopeptidase 1 (ERAP1), a key regulator of innate and adaptive antitumor immune responses, as a previously unknown player in the Hh signaling pathway. We demonstrate that ERAP1 binds the deubiquitylase enzyme USP47, displaces the USP47-associated ßTrCP, the substrate-receptor subunit of the SCFßTrCP ubiquitin ligase, and promotes ßTrCP degradation. These events result in the modulation of Gli transcription factors, the final effectors of the Hh pathway, and the enhancement of Hh activity. Remarkably, genetic or pharmacological inhibition of ERAP1 suppresses Hh-dependent tumor growth in vitro and in vivo. Our findings unveil an unexpected role for ERAP1 in cancer and indicate ERAP1 as a promising therapeutic target for Hh-driven tumors.


Assuntos
Aminopeptidases/fisiologia , Antígenos de Histocompatibilidade Menor/fisiologia , Proteases Específicas de Ubiquitina/metabolismo , Proteínas Contendo Repetições de beta-Transducina/metabolismo , Aminopeptidases/genética , Aminopeptidases/metabolismo , Animais , Carcinogênese/genética , Proteínas Hedgehog/metabolismo , Camundongos , Antígenos de Histocompatibilidade Menor/genética , Antígenos de Histocompatibilidade Menor/metabolismo , Células NIH 3T3 , Estabilidade Proteica , Proteólise , Transdução de Sinais
8.
Cells ; 8(2)2019 01 29.
Artigo em Inglês | MEDLINE | ID: mdl-30699938

RESUMO

Hedgehog signalling (Hh) is a developmental conserved pathway strongly involved in cancers when deregulated. This important pathway is orchestrated by numerous regulators, transduces through distinct routes and is finely tuned at multiple levels. In this regard, ubiquitylation processes stand as essential for controlling Hh pathway output. Although this post-translational modification governs proteins turnover, it is also implicated in non-proteolytic events, thereby regulating the most important cellular functions. The HECT E3 ligase Itch, well known to control immune response, is emerging to have a pivotal role in tumorigenesis. By illustrating Itch specificities on Hh signalling key components, here we review the role of this HECT E3 ubiquitin ligase in suppressing Hh-dependent tumours and explore its potential as promising target for innovative therapeutic approaches.


Assuntos
Proteínas Hedgehog/metabolismo , Transdução de Sinais , Ubiquitina-Proteína Ligases/metabolismo , Ubiquitinação , Animais , Humanos , Modelos Biológicos
9.
Eur J Med Chem ; 156: 554-562, 2018 Aug 05.
Artigo em Inglês | MEDLINE | ID: mdl-30025349

RESUMO

Aberrant activation of the Hedgehog (Hh) pathway is responsible for the onset and progression of several malignancies. Small molecules able to block the pathway at the upstream receptor Smoothened (Smo) or the downstream effector Gli1 have thus emerged recently as valuable anticancer agents. Here, we have designed, synthesized, and tested new Hh inhibitors taking advantage by the highly versatile and privileged isoflavone scaffold. The introduction of specific substitutions on the isoflavone's ring B allowed the identification of molecules targeting preferentially Smo or Gli1. Biological assays coupled with molecular modeling corroborated the design strategy, and provided new insights into the mechanism of action of these molecules. The combined administration of two different isoflavones behaving as Smo and Gli antagonists, respectively, in primary medulloblastoma (MB) cells highlighted the synergistic effects of these agents, thus paving the way to further and innovative strategies for the pharmacological inhibition of Hh signaling.


Assuntos
Proteínas Hedgehog/antagonistas & inibidores , Isoflavonas/química , Isoflavonas/farmacologia , Transdução de Sinais/efeitos dos fármacos , Receptor Smoothened/antagonistas & inibidores , Proteína GLI1 em Dedos de Zinco/antagonistas & inibidores , Animais , Antineoplásicos/química , Antineoplásicos/farmacologia , Células Cultivadas , Neoplasias Cerebelares/tratamento farmacológico , Neoplasias Cerebelares/metabolismo , Desenho de Fármacos , Proteínas Hedgehog/metabolismo , Humanos , Meduloblastoma/tratamento farmacológico , Meduloblastoma/metabolismo , Camundongos , Modelos Moleculares , Receptor Smoothened/metabolismo , Células Tumorais Cultivadas , Proteína GLI1 em Dedos de Zinco/metabolismo
10.
Nat Commun ; 9(1): 976, 2018 03 07.
Artigo em Inglês | MEDLINE | ID: mdl-29515120

RESUMO

Suppressor of Fused (SuFu), a tumour suppressor mutated in medulloblastoma, is a central player of Hh signalling, a pathway crucial for development and deregulated in cancer. Although the control of Gli transcription factors by SuFu is critical in Hh signalling, our understanding of the mechanism regulating this key event remains limited. Here, we show that the Itch/ß-arrestin2 complex binds SuFu and induces its Lys63-linked polyubiquitylation without affecting its stability. This process increases the association of SuFu with Gli3, promoting the conversion of Gli3 into a repressor, which keeps Hh signalling off. Activation of Hh signalling antagonises the Itch-dependent polyubiquitylation of SuFu. Notably, different SuFu mutations occurring in medulloblastoma patients are insensitive to Itch activity, thus leading to deregulated Hh signalling and enhancing medulloblastoma cell growth. Our findings uncover mechanisms controlling the tumour suppressive functions of SuFu and reveal that their alterations are implicated in medulloblastoma tumorigenesis.


Assuntos
Proteínas Hedgehog/metabolismo , Meduloblastoma/metabolismo , Proteínas Repressoras/metabolismo , Ubiquitina-Proteína Ligases/metabolismo , beta-Arrestina 2/metabolismo , Motivos de Aminoácidos , Animais , Carcinogênese , Feminino , Proteínas Hedgehog/genética , Humanos , Meduloblastoma/enzimologia , Meduloblastoma/genética , Meduloblastoma/patologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos NOD , Camundongos Knockout , Camundongos SCID , Proteínas Repressoras/química , Proteínas Repressoras/genética , Transdução de Sinais , Ubiquitina-Proteína Ligases/genética , Ubiquitinação , beta-Arrestina 2/genética
11.
Curr Pharm Des ; 24(36): 4251-4269, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30636589

RESUMO

It is nowadays widely accepted that some tumors have a niche of cells endowed with stemness features, which may cause resistance to conventional anticancer therapies and relapse/recurrence of the malignancy. These cells are usually referred to as cancer stem cells (CSCs) and, different from normal cancer cells, are rather quiescent. Targeting CSCs is thus a highly challenging but promising strategy to counteract tumor growth, and to develop innovative anticancer agents. Here, we review the chemical, biological and multidisciplinary efforts that have been spent in targeting CSCsspecific signaling pathways Notch and Hedgehog (Hh) for anticancer drug discovery. In particular, the use of natural products as a valuable source of lead compounds or chemical biology tools is emphasized. Examples of natural products functionalization through semi-synthetic transformations or total syntheses, aimed at improving pharmacokinetics and/or pharmacodynamics properties of natural products in Notch or Hh inhibition, are provided as well.


Assuntos
Antineoplásicos/farmacologia , Produtos Biológicos/farmacologia , Células-Tronco Neoplásicas/efeitos dos fármacos , Animais , Antineoplásicos/farmacocinética , Produtos Biológicos/farmacocinética , Desenvolvimento de Medicamentos/métodos , Descoberta de Drogas/métodos , Proteínas Hedgehog/efeitos dos fármacos , Proteínas Hedgehog/metabolismo , Humanos , Terapia de Alvo Molecular , Neoplasias/tratamento farmacológico , Neoplasias/patologia , Células-Tronco Neoplásicas/patologia , Receptores Notch/efeitos dos fármacos , Receptores Notch/metabolismo , Transdução de Sinais/efeitos dos fármacos
12.
Cell Death Dis ; 7(9): e2376, 2016 09 22.
Artigo em Inglês | MEDLINE | ID: mdl-27899820

RESUMO

Hedgehog (Hh) inhibitors have emerged as valid tools in the treatment of a wide range of cancers. Indeed, aberrant activation of the Hh pathway occurring either by ligand-dependent or -independent mechanisms is a key driver in tumorigenesis. The smoothened (Smo) receptor is one of the main upstream transducers of the Hh signaling and is a validated target for the development of anticancer compounds, as underlined by the FDA-approved Smo antagonist Vismodegib (GDC-0449/Erivedge) for the treatment of basal cell carcinoma. However, Smo mutations that confer constitutive activity and drug resistance have emerged during treatment with Vismodegib. For this reason, the development of new effective Hh inhibitors represents a major challenge for cancer therapy. Natural products have always represented a unique source of lead structures in drug discovery, and in recent years have been used to modulate the Hh pathway at multiple levels. Here, starting from an in house library of natural compounds and their derivatives, we discovered novel chemotypes of Hh inhibitors by mean of virtual screening against the crystallographic structure of Smo. Hh functional based assay identified the chalcone derivative 12 as the most effective Hh inhibitor within the test set. The chalcone 12 binds the Smo receptor and promotes the displacement of Bodipy-Cyclopamine in both Smo WT and drug-resistant Smo mutant. Our molecule stands as a promising Smo antagonist able to specifically impair the growth of Hh-dependent tumor cells in vitro and in vivo and medulloblastoma stem-like cells and potentially overcome the associated drug resistance.


Assuntos
Chalconas/farmacologia , Proteínas Hedgehog/metabolismo , Neoplasias/metabolismo , Células-Tronco Neoplásicas/metabolismo , Animais , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Chalconas/química , Avaliação Pré-Clínica de Medicamentos , Células HEK293 , Humanos , Camundongos , Células NIH 3T3 , Neoplasias/patologia , Células-Tronco Neoplásicas/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos , Bibliotecas de Moléculas Pequenas/química , Bibliotecas de Moléculas Pequenas/farmacologia , Receptor Smoothened/antagonistas & inibidores , Receptor Smoothened/metabolismo
13.
Rev. CEP-PA ; 21: 119-137, 2014.
Artigo em Português | Index Psicologia - Periódicos | ID: psi-62330

RESUMO

O objetivo deste trabalho é, baseado na história de amor do filme "As Pontes de Madison", suscitar algumas reflexões relativas a encontros e desencontros, sob uma perspectiva psicanalítica, tais como: pensar nas relações amorosas e no percurso feito durante o desenvolvimento psíquico; pensar no desejo, no conflito e na necessidade de fazer escolhas; refletir sobre os objetos amorosos que nos constituem como sujeitos e nas mudanças psíquicas geradas por esses encontros, apoiando-nos em textos de Freud e de alguns outros autores.(AU)


The objective of this work is, based on the love story of the movie "The Bridges of Madison ", raise some reflections on meetings and disagreements, under an psychoanalytic perspective. To think about love relationships and route taken by the phases of psychic development. To think in the desire, conflict and the need to make choices. To reflect on the love-objects that constitute us as subjects and in the psychic changes generated by these meetings, supporting us on Freud's texts and some other authors. (AU)


El objetivo de este trabajo es, baseado en la historia de amor de la película "Los puentes de Madison", plantear algunas reflexiones sobre encuentros y desencuentros en una perspectiva psicoanalítica. Piensar acerca de las relaciones de amor y ruta adoptadas por las fases del desarrollo psíquico. Piensar en el deseo, en el conflicto y en la necesidad de tomar decisiones. Reflexionar sobre los objetos de amor que nos constituyen como sujetos y los cambios psíquicos generados por eses encuentros, apoyándonos en textos de Freud y de algunos otros autores. (AU)

14.
Rev. CEP-PA ; 19: 179-186, 2012.
Artigo em Português | Index Psicologia - Periódicos | ID: psi-55385

RESUMO

Este ensaio literário começou a ser pensado a partir da leitura do clássico “O Morro dos Ventos Uivantes”, obra que despertou nosso interesse e provocou associações com nosso estudo teórico e também com a prática clínica. As relações estabeleceram-se principalmente em torno do narcisismo como fator determinante na constituição do sujeito. O texto proposto a seguir tem a pretensão maior de questionar as relações narcísicas atuais, tanto no sentido interno quanto no cronológico. Isto é, como a clínica atual tem cada vez mais nos apresentado situações de difícil manejo pelas questões narcísicas prevalentes, achamos interessante nos valermos de um texto literário do início do século passado, para exercitar essas associações através da escrita. Não se tem a intenção de aprofundar nenhum conceito psicanalítico, porque para tanto uma obra literária não seria o melhor recurso. Este ensaio fará pinceladas por conceitos teóricos, escritos literários e filosóficos, tentando comunicar a intensidade da dor dos sujeitos quando o narcisismo constitui-se debilmente. O personagem Heathcliff foi tomado como modelo, apresentando-se como um agressor/carente que vive em um “morro”, o qual nos remeteu constantemente, durante a leitura do romance, à dualidade vida e morte que circunda a existência dos sujeitos.(AU)


Este trabajo tomo un clásico de la literatura, Cumbres Borrascosas, como apoyo literario para pensar el narcisismo como factor determinante en la constituición del sujeto. Pincelando por lá técnica, por la psicopatologia, por conceptos teóricos, escritos literarios y filosóficos, se intentó descifrar un poco más los colores que figuran en la pantalla de la vida de los sujetos. El personaje Heathcliff sirvió de inspiración, presentando una “cumbre” y remitiendo a la dualidad vida y muerte que circunda la existencia de los sujetos.(AU)


The work addresses a literary classic, The Wuthering Heights, as literary support for thinking the narcissism as a determining factor in the consitution of the subject. The technique, the psychopathology, theoretical concepts, literary and philosophical writings have been brushed in an attempt to decipher a few more colours that appear on the canvas of subjects' lives. Heathcliff, the character, was as inspiration, presenting a “hill” and referring to the duality of life and death that surrounds the existence of subjects.(AU)

15.
Rev. CEP-PA ; 11: 147-149, 2004.
Artigo em Português | Index Psicologia - Periódicos | ID: psi-33010
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...